NCT/Study#

CPX351/VYXEOS

Phase IB/II of CPX-351 as maintenance therapy in AML patients ineligible for bone marrow transplantation

Phase IB/II of CPX-351 as maintenance therapy in AML patients ineligible for bone marrow transplantation

DISEASE GROUP:
Leukemia
current phase:
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: